Information about Belpharma
My details
*
*
*

Belpharma (SA)

BE 0447.683.110

Avenue Joseph Abras(BL) 54, 5001 Namur

Company information

Status
Active

Enterprise number

BE0447.683.110

VAT liability
Yes
Established
25-06-1992
Last balance sheet year
2025
Company size
Small 1 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Belpharma

2025 2024 2023 2022
Profit/Loss € 62,368 46 % € 42,745 -36 % € 66,700 9 % € 61,371
Equity € 425,779 -7 % € 459,077 6 % € 431,333 14 % € 379,633
Gross margin € 134,068 15 % € 116,277 -16 % € 138,111 2 % € 135,365
Employees 1 0.6 0.9 0.8

Publications from Belpharma

Date Publication
01-06-2023 Resignations, Appointments (FR)
09-07-2021 Resignations, Appointments (FR)
09-06-2015 Resignations, Appointments (FR)
02-02-2012 Capital, Shares (FR)
08-06-2009 Resignations, Appointments (FR)

Frequently asked questions

What is the VAT number of Belpharma?
The VAT number of Belpharma is BE 0447.683.110.
Wat is the PEPPOL ID of Belpharma?
The PEPPOL ID of Belpharma is 0208:0447683110. Log in or start a free trial to see the full overview.
When was Belpharma founded?
Belpharma was founded on 25-06-1992.
What is the address of Belpharma?
The current registered office of Belpharma is located at Avenue Joseph Abras(BL) 54, 5001 Namur.
When was the last time Belpharma filed their annual financial statements?
The most recent financial statements of Belpharma were filed on 01-06-2026.
How many employees does Belpharma have?
There are 1 FTEs working at Belpharma according to the staff figures in the most recent financial statements.
What is the annual turnover of Belpharma?
At the time of its most recent financial statements, Belpharma did not publish any turnover figures. Belpharma reported a gross margin of €134,068.08.

Sources